D-dimer Test Market By Testing Method, By Disease Type (Deep Vein Thrombosis, Pulmonary Embolism, And Other), By End User (Hospitals, Clinics, Research Institutes, And Others), And Region - Global Forecast To 2028
30th April 2019
- find_in_page Our Research Methodology is based on the following main points:
- Data Collections and Interpretation
- Data Validation
- Final Projections and Conclusion
The global D-dimer test market is estimated to value of over US$ 2.0 Bn in 2019, and is projected to register a CAGR of 5.3%. The global D-dimer test market is segmented on the basis of testing method, disease type, end user, and region.
Global D-Dimer Test Market: Introduction
D-dimer is a protein fragments produced when a blood clot dissolves in the body. It is also known as fragment D-dimer and fibrin degradation fragment. The D-dimer test is used to detect level of D-dimer in the blood that rises when there is significant formation and breakdown of blood clots in the body. D-dimer test is used to help diagnose disseminated intravascular coagulation and to monitor the effectiveness of DIC treatment. It is being routinely used in the first-line assessment of patients of suffering venous thromboembolism.
Global D-Dimer Test Market: Dynamics
Increasing incidence of thromboembolic disease, which includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is one among some of the key drivers projected to drive growth of the global D-dimer test market. On average each year, approximately 10 million cases are reported worldwide. In addition, increasing prevalence of blood-related disorders such as platelet disorders, excessive clotting, bleeding problems, blood cancers etc., is a factor expected to result in an expanding patient pool globally, thereby driving demand for D-dimer tests. Increasing geriatric population across the globe has prompted development and delivery of advanced technology in order to treat thrombotic disorder and diseases is expected to fuel growth of the target market to significant extent over the forecast period.
Moreover, increasing investments by major players towards advanced technological development of new innovative D-dimer devices and assays with advanced features and designs considering mobility, size, and weight for testing blood clot disorders. This is expected to drive demand for D-dimer test. Furthermore, increasing adoption of point-of-care testing devices and testing for quantitative as well as qualitative measurement of cross-linked fibrin degradation products in human citrated or heparinized plasma. Point-of-Care technologies offers fast turnaround times which help to speed up diagnosis and treatment processes, increases clinical efficiency, mitigate overcrowding in hospitals and diagnostic service providers, reduce contingencies and process costs. This is expected to fuel growth of the target market to significant extent over the forecast period.
Increasing focus on development of more advanced and efficient devices with standardization in order to reduce confusion and allow wider use of threshold adjustment to the benefit of patients can create revenue opportunities for existing as well as new entrants in the global market.
However, product recalls by manufacturers to address problems related to medical devices that violate or do not adhere or comply with government regulations, as well as high cost of procedures have a negative impact on growth of D-dimer test market. In addition, dearth of skilled personnel and imaging dye administration may increase risk of renal failure are other factors expected to restrain revenue growth of target market over the forecast period.
Analysis by Testing Methods:
On the basis of testing method segmentation, the laboratory testing segment is expected to contribute major revenue share to the global market and is expected to maintain its dominance over the forecast period. The point-of-care testing segment register highest CAGR over 5.2%. Increasing adoption of point-of-care testing devices and testing for quantitative as well as qualitative measurement of cross-linked fibrin degradation products is a major factor expected to drive revenue growth of the segment over the forecast period.
Analysis by Disease Type:
Among all the disease type segments, the deep vein thrombosis segment accounts for highest share in terms of revenue in the global market. The deep vein thrombosis segment witnesses a CAGR over 5.3%. High prevalence of thromboembolic disease, coupled with growing awareness among consumers, increasing geriatric population, and others are major factors expected to drive revenue growth of the deep vein thrombosis segment over the forecast period.
Analysis by End User:
Among all the end user segments, the hospitals segment accounts for highest share in terms of revenue in the global market and witnesses a CAGR over 5.3%. Increasing prevalence of blood related disorders such as platelet disorders, excessive clotting, bleeding problems, blood cancers, etc., and rising incidence and mortality rate of pulmonary embolism and deep-vein thrombosis in developed as well as developing countries are major factors expected to drive revenue growth of the hospitals segment over the forecast period.
Analysis by Region:
The market in North America is estimated to account for highest growth in terms of revenue during the forecast period. High prevalence of thromboembolic disease and increasing adoption of automated blood coagulation analyzer in diagnosing thrombotic diseases such as myocardial and cerebral infarction are factors expected to drive growth of the North America market. In addition, prolonged immobility owing to hectic lifestyle can cause stiffness, swelling, and discomfort, which may lead to blood clots in deep vein causing deep vein thrombosis is a factor increasing demand for D-dimer test in the region.
The Europe market accounted for considerable share in terms of revenue in the global market. Changing lifestyle, coupled with busy schedule and long journeys via flights, trains, bus, or car, especially when seated for periods, can lead to Chronic Venous Insufficiency (CVI), which in turn increase demand for D-dimer test. Additionally, increasing adoption of point-of-care testing devices and testing for measurement of cross-linked fibrin degradation products in human citrated or heparinized plasma is among some major factors expected to drive growth of the North America D-dimer test market to a significant extent.
The market in Asia Pacific is expected to account for moderate growth in terms of revenue, and is projected to register highest CAGR of over 5.5% over the forecast period. Increasing initiatives and investments by various governments and leading organizations to improve health care infrastructure, human resource development and capacity building, and regulations in the public health domain is a factor expected to fuel growth of the Asia Pacific D-dimer test market over the forecast period.
The market in Latin America register a CAGR of over 4.5% in the global market over the forecast period, followed by Middle East & Africa. Increasing geriatric population and increasing prevalence of blood related disorders are factors which in turn drive revenue growth of the target market over the forecast period.
Global D-dimer test market segmentation:
Segmentation On the Basis of Testing Method:
- Point-of-care (POCT) Testing
- Laboratory Testing
- Coagulation Analyzers
- Clinical Chemistry Analyzers
Segmentation On the Basis of Disease Type:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism
- Disseminated Intravascular Coagulation (DIC)
Segmentation On the Basis of End User:
- Research Institutes
- Diagnostics Laboratories
- Assisted Living Healthcare Facilities
- Ambulatory Surgical Centers
Segmentation On the Basis of Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- Abbott Laboratories
- Danaher Corp. (Beckman Coulter, Inc.)
- Bio-Rad Laboratories, Inc.
- Roche Holding AG (F. Hoffmann-La Roche Ltd.)
- Siemens Healthineers AG
- Helena Laboratories Corporation (Helena Laboratories (UK) Limited)
- Sysmex Corporation
- bioMérieux S.A.
- WerfenLife, S.A. (Instrumentation Laboratory Company)
- HORIBA, Ltd.
- Chapter 1 Global D-Dimer Test Market Overview
- 1.1 Introduction
- 1.2 Taxonomy
- 1.2.1 By Testing Methods, Disease Type, and End Users
- 1.2.2 By Region
- 1.3 Drivers for D-Dimer Test Market
- 1.4 Restraints for D-Dimer Test Market
- 1.5 Opportunities for D-Dimer Test Market
- 1.6 Trends for D-Dimer Test Market
- 1.7 Value Chain Analysis
- 1.8 Manufacturing Cost Analysis
- 1.9 Pricing Analysis – Assay
- 1.10 Pricing Analysis – Instrument
- 1.11 Regulatory Scenario
- Chapter 1 Global D-Dimer Test Market Overview
Request for Customization
Don't just take our word. We are trusted by these great companies!